Among the compounds tested, CHEMBL1075867, a radical scavenger derivative, exhibited the strongest binding to SOD1, outperforming edaravone, the only FDA-approved radical scavenger for ALS. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.